Patents Assigned to Cormend Technologies, LLC
  • Patent number: 9931375
    Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: April 3, 2018
    Assignee: CORMEND TECHNOLOGIES, LLC
    Inventors: William P. Santamore, Jeanne M. Lesniak
  • Publication number: 20160279200
    Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.
    Type: Application
    Filed: May 27, 2016
    Publication date: September 29, 2016
    Applicant: Cormend Technologies, LLC
    Inventors: William P. SANTAMORE, Jeanne M. LESNIAK
  • Publication number: 20160235820
    Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying at least one target region of the myocardium of the heart to be treated; and injecting a keratin-based material that travels to at least one target region to at least one of stiffen, restrain, or constrain the myocardial tissue of the target region. The material applied results in a physical modification of the mechanical properties, including stiffness, of the infarct tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.
    Type: Application
    Filed: February 17, 2016
    Publication date: August 18, 2016
    Applicant: Cormend Technologies, LLC
    Inventor: John C. ANDRES
  • Patent number: 9381157
    Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: July 5, 2016
    Assignee: CORMEND TECHNOLOGIES, LLC
    Inventors: William P. Santamore, Jeanne M. Lesniak
  • Patent number: 8936027
    Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.
    Type: Grant
    Filed: May 26, 2011
    Date of Patent: January 20, 2015
    Assignee: Cormend Technologies, LLC
    Inventors: William P. Santamore, Jeanne M. Lesniak
  • Patent number: 8452419
    Abstract: Medical devices and therapeutic methods for use in the field of cardiology, cardiac rhythm management and interventional cardiology, and more specifically to catheter-based systems for implantation of pacing leads and electrodes, or intramural myocardial reinforcement devices, within the myocardial wall of the heart, such as the ventricles, to provide improved cardiac function.
    Type: Grant
    Filed: July 12, 2010
    Date of Patent: May 28, 2013
    Assignee: Cormend Technologies, LLC
    Inventors: William P. Santamore, Jeanne M. Lesniak
  • Publication number: 20120109044
    Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.
    Type: Application
    Filed: May 26, 2011
    Publication date: May 3, 2012
    Applicant: CORMEND TECHNOLOGIES, LLC
    Inventors: William P. Santamore, Jeanne M. Lesniak
  • Patent number: 7988727
    Abstract: A method for direct therapeutic treatment of myocardial tissue in a localized region of a heart having a pathological condition. The method includes identifying a target region of the myocardium and applying material directly and substantially only to at least a portion of the myocardial tissue of the target region. The material applied results in a physically modification the mechanical properties, including stiffness, of said tissue. Various devices and modes of practicing the method are disclosed for stiffening, restraining and constraining myocardial tissue for the treatment of conditions including myocardial infarction or mitral valve regurgitation.
    Type: Grant
    Filed: October 4, 2004
    Date of Patent: August 2, 2011
    Assignee: Cormend Technologies, LLC
    Inventors: William P. Santamore, Jeanne M. Lesniak